Literature DB >> 29719119

Thermoregulatory profile of neurodegeneration-induced dementia of the Alzheimer's type using intracerebroventricular streptozotocin in rats.

A C P Motzko-Soares1, R C L Vizin1, T M S Martins2, A R O Hungaro2, J R Sato1,3, M C Almeida1,4, D C Carrettiero1,4.   

Abstract

AIM: Here, we have extensively investigated the relationship between thermoregulation and neurodegeneration-induced dementia of the Alzheimer's type using intracerebroventricular injections of streptozotocin (icv-STZ).
METHODS: Male Wistar rats were treated with bilateral injections of icv-STZ, and their thermoregulatory profiles (core body temperature, tail-skin temperature, cold and heat defence responses and thermal place preference) were evaluated. Spatial memory, locomotor activity, social interaction, brain ventricular volume, and Aβ1-42 and tau protein levels in the brain were analysed to characterize the effects of STZ on the brain and behaviour.
RESULTS: In addition to deficits in spatial memory, reduced social interaction and an increased brain ventricular volume, icv-STZ rats presented a pattern of hyperthermia, as demonstrated by an increased core body temperature. Hyperthermia was due to the activation of both autonomic heat conservation and behavioural cold avoidance, as STZ-treated rats presented tail-cutaneous vasoconstriction and an altered thermal preference. They also showed a distinct cold defence response when exposed to cold.
CONCLUSION: Our data bring evidence that icv-STZ in rats causes hyperthermia, with activation of both autonomic and behavioural thermoregulatory defence responses when challenged at colder temperatures, leading us to hypothesize that they are more efficient in preventing hypothermia. These data are relevant for a better understanding of neurodegenerative disease mechanisms.
© 2018 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Alzheimer's disease; cognitive decline; cold avoidance; hyperthermia; memory loss; thermoregulation

Mesh:

Substances:

Year:  2018        PMID: 29719119     DOI: 10.1111/apha.13084

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  3 in total

1.  Intracerebral Injection of Streptozotocin to Model Alzheimer Disease in Rats.

Authors:  Daniel Moreira-Silva; Robson C L Vizin; Talita M S Martins; Tatiana L Ferreira; Maria C Almeida; Daniel C Carrettiero
Journal:  Bio Protoc       Date:  2019-10-20

Review 2.  Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease.

Authors:  Jelena Osmanovic Barilar; Ana Knezovic; Ana Babic Perhoc; Jan Homolak; Peter Riederer; Melita Salkovic-Petrisic
Journal:  J Neural Transm (Vienna)       Date:  2020-02-06       Impact factor: 3.575

3.  Anandamide Effects in a Streptozotocin-Induced Alzheimer's Disease-Like Sporadic Dementia in Rats.

Authors:  Daniel Moreira-Silva; Daniel C Carrettiero; Adriele S A Oliveira; Samanta Rodrigues; Joyce Dos Santos-Lopes; Paula M Canas; Rodrigo A Cunha; Maria C Almeida; Tatiana L Ferreira
Journal:  Front Neurosci       Date:  2018-09-21       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.